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A B S T R A C T
A rare case of multiple symmetric lipomatosis type 2 in a female patient was presented. New possible iconographic
representations of multiple symmetric lipomatosis were considered and some metabolic aspects of this disease were re-
viewed.
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Introduction
Since ancient times morbid conditions were portrayed
by artists, most often without intention and any medical
knowledge. They anticipated and sometimes surpassed
descriptions in scientific world. This unique expressive-
ness of art objects contributed to the paleopathology as
much as written medical scripts, pathography of histori-
cal persons or study of human remains1,2. The importan-
ce and richness of particular iconographic sources leaded
in 1983 to the introduction of the term iconodiagnosis3.
Being a disfiguring disease, the wide spectrum of ico-
nographic representation of obesity exists in figurative
arts and archaeological findings through the time. A dif-
ferent perception of obesity in particular civilization was
reflected through the artist’s eye: for instance, in Greek
figures as grotesque and despised, or in Etruscans as a
symbol of wealth and well-being4,2. Particularly interesti-
ng have been figures from illiterate populations, statuet-
tes of women, so called »stone-age Venuses«. They al-
lowed Pontius, the founder of the term »iconodiagnosis«,
to depict and differentiate between two main types of
obesity: abdominal and gluteal5. On the other hand, ar-
chaeologists interpreted the most famous early image of
a human, a woman called »Venus of Willendorf« as an
ideal of beauty and fertility of this age. However, from
the medical point of view this might be contested because
such abdominal type of obesity is supposed to interfere
with reproduction2.
Recently, going further in depicting some ancient rep-
resentations of obesity, a rare syndrome, multiple sym-
metric lipomatosis (MLS) was recognized6. This particu-
lar disorder with characteristic distribution of fat should
be considered in differential diagnosis of obesity. This is a
disease of massive fat accumulation under the skin and
presents in at least two different clinical phenotypes:
type 1 with fat deposits mainly around the neck and up-
per trunk and type 2 with fat deposits mainly in proximal
limbs, saving the distal segments, creating in such a way
a pseudoathletic, massive aspect7.
Case Report
We present a case of a 48 years old female patient who
presented with characteristic clinical phenotype of type 2
MSL. She attended our endocrinology outpatient unit
complaining on large masses on both her arms. The en-
largement has especially increased in the last 3 months,
but has appeared and has been slowly accumulating for
at least 3 years, the time coinciding with the onset of her
menopause. She had no other complaints relating to the
excess of adipose tissue, but her weight increased since
then 20 kg, reaching 83 kg with body mass index of 36
and waist circumference of 98 cm. The rest of her past
history was unremarkable besides alcohol intake of
about 40 g daily. Physical examination revealed obvious
symmetrical fat deposits in upper arms and shoulders
(Figure 1). She presented a characteristic pseudoathletic
appearance but also exhibited prominent abdominal and
lower part of the body obesity.
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Routine laboratory evaluation disclosed evidence of
chronic liver disease with two-fold increase of transami-
nases. Fasting cholesterol and its subfractions, as well as
fasting triglycerides, were within the normal range. By
performing oral glucose tolerance test and measuring he-
moglobin A1c, we found no laboratory signs for diabetes
mellitus. The measurement of fasting thyroid-stimulat-
ing hormone, cortisol, adrenocorticotropic hormone,
IGF-1, prolactin, testosterone, luteinizing and follicle-sti-
mulating hormone revealed no abnormalities but she
had a relatively low estradiol level.
Microscopy of the sample obtained by cytological pun-
cture revealed benign adipose tissue with normal cell dia-
meter. Further examinations consisted of magnetic reso-
nance that described the nonencapsulated adipose tissue
in shoulder region with the largest diameter of 7 cm. Bo-
dy composition determined by densitometry showed that
she had 47.6 % body fat. Abdominal ultrasound confir-
med hepatic steatosis. Electromyoneurography showed a
beginning of motoric neuronal lesion in cervical and lum-
bal segment. The patient still considers whether to be op-
erated and the method of choice would be liposuction8.
Discussion
The first studies of MSL go back to 1846 by B. C. Bro-
die, who described a picture of symmetrical lipomatosis,
particularly in the neck9. In 1888 Otto W. Madelung
clearly described the syndrome in 33 cases in his work
»Ueber den Fetthals«10. In 1898 P. E. Launois and R.
Bensaude wrote »De adénolipomatose simmétrique« and
accurately presented 75 cases of such a rare disease11.
Besides being rare in clinical setting, the possible rec-
ognition of this disease in following archaeological find-
ings engaged vivid discussions12,13.
An ancient relief from Deir el-Bahri shows Queen of
Punt offering gifts to the Queen Egyptian Hatshepsut
(1473–1458 B.C.). Discerning the alleged pathological ap-
pearance of Queen of Punt, syndromologists found hyper-
lordosis, gluteofemoral obesity and symmetrically distri-
buted deposits on the trunk, arms and thighs, sparing
her face, neck, hands and feet. In the absence of her
mummy, differential diagnosis of the Queen’s phenotype
resulted in a puzzle of several pathologic entities, among
others: steatopygy, myxoedema, rickets, bilateral congen-
ital hip dislocations, achondroplasia, neurofibromatosis
and finally MSL14.
The second example is the CapestranoWarrior discov-
ered in Abruzzi region, a naturalistic monumental stone
sculpture of the native Italic fighter being over two and
one-half meters tall, from approximately sixth century
B.C. The Warrior is sculpted with unnaturally big hips
and wide shoulders and although some have considered
it as eunuch, there has been undoubtedly striking resem-
blance with MSL6,13.
From nearly the same period and from Germany,
»Warrior of Hirschlanden« shows stylistic similarities to
the Capestrano one. This fact was used in argument
against pathological interpretation of their features13.
However, unproportionaly robust legs, slender upper bo-
dy and tiny head of the »Warrior of Hirschlanden« might
be characteristics of an other disorder, the acquired par-
tial lipodistrophy (Barraquer-Simons syndrome) which
consist of loss of fat from face, neck and trunk and accu-
mulation of excess fat in the hips and the rest of lower
limbs15.
In our research, Queen of Punt and Capestrano War-
rior haven’t been the only possible iconographic repre-
sentation of MSL. The well-known Gimbutas’ book on
»Goddesses and Gods of Old Europe« has been a rich col-
lection of pictures of Neolithic figures. Pontius used it in
differentiating types of obesity and it allowed us to go a
step further16,5. Bearing in mind the type 2 MSL clinical
phenotype, we have found several figures with unnatu-
rally wide shoulders and large arms, for example, from
Sesklo, Thessaly in Greece, from sixth millennium B.C
(Figure 2). They might have been inspired by pseudoat-
hletic appearance of MSL as well16,5.
The enigma would remain whether these had been ca-
ses of MSL, other form of obesity or artistic pseudopatho-
logy. The reality of artist is not always a physical reality.
The artistic regard originates from cultural and spiritual
context and reflects broader aspects of the civilization16.
Recognizing this nowadays-rare pathology in ancient
sculptures might be burdened with controversies but
even the occurrence of simple obesity in both Venuses
from Paleolithic and Goddesses from Neolithic era is con-
troversial. Obesity as a consequence of sedentary lifes-
tyle is in contradiction with the actual way of life in that
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Fig. 1. Upper torso of our patient with multiple symmetric lipo-
matosis.
Fig. 2. Upper torso of goddess with massive shoulders and arms,
Sesklo, Thessaly, 6000 B.C. (photo: courtesy of the National Ar-
chaeological Museum, Athens).
time17. The contemporary incidence of MSL in countries
around the Mediterranean is not unusual18. Authors ha-
ve already speculated about genetic relation and possible
inheritance of this disease from an ancient Mediterra-
nean population6. Could it be that this phenotype was
more common in ancient time? Possible answers lay in
its future genetic dissection.
More than 400 hundreds cases have been reported
since the first descriptions of MSL, but its etiology remai-
ns obscure. First hypotheses interpreted MSL as a defect
in the adrenergic stimulated lipolysis19. The disease has
also been suppose to originate from brown adipose tissue
(BAT)20. The recent study of the genes’ expression con-
firmed that MSL cells express the UCP-1 gene, the speci-
fic biochemical marker of BAT, although functionally de-
regulated BAT because of its defective lipolytic response
to catecholmanines21.
Mitochondrial dysfunction has been associated with
alterations of fat metabolism in several disorders and it
seems to be a crucial mechanism involved in the develop-
ment of lipomatosis22. Cases with point mitochondrial
DNA mutations were documented but those mutations
do not occur in the typical disease23,24. However, patients
with MSL, just as in our case, often suffer from chronic
alcoholic hepatopathy. As alcohol has been admitted to
interfere with mitochondrial metabolism, this is proba-
bly an important link to the pathogenesis of MSL25.
Some results indicated decreased insulin resistance in
patients with MSL26,27. Accumulation of subcutaneous
fat leads to change of subcutaneous to visceral fat con-
tent ratio, reducing the insulin resistance analogous to
the thiazolidinedione action. This was supposed to pres-
ent a more metabolically benign mean of increasing en-
ergy stores and an attractive hypothesis that MSL might
be a paradigm of metabolically innocent obesity appe-
ared26,27. However, caution is suggested because the con-
clusion of good insulin sensitivity in MSL patients should
not be generalized. There is a considerable clinical and
phenotypic variability in patients with MSL, some being
reported to have diabetes28,29.
Conclusions
We have presented here a case of type 2 MSL, disorder
especially rare in females. Considering its strong similar-
ity with simple obesity, we think that it might be an un-
der recognized syndrome as well among famous Gim-
buta’s »Goddesses of Old Europe« as in actual clinical
practice16. The particular pathognomonic appearance
might be concealed or become less evident when occur-
ring together with simple obesity, especially in older indi-
viduals. Critical but not skeptical approach to ancient art
and other paleopathological data might allow us to ex-
pect further contributions to iconodiagnosis2,5.
Until recently adipose tissue was regarded as a passi-
ve depot of lipids, but increasing evidence points to an
important role of adipocytes as a complex and active en-
docrine organ and adipocytokines play a major role in
whole body metabolism. MSL might present a captivat-
ing paradigm for new concepts in this field.
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OD DREVNIH ENIGMA DO NOVIH PARADIGMA: PRIKAZ MULTIPLE SIMETRI^NE LIPOMATOZE
S A @ E T A K
Opisan je rijedak slu~aj bolesnice s multiplom simetri~nom lipomatozom tipa 2. Razmotreni su novi mogu}i ikono-
grafski prikazi multiple simetri~ne lipomatoze te su iznijete spoznaje o metaboli~kim aspektima te bolesti.
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